Join
Live feed
·
INSIDERFilingvia Quantisnow
Aktis Oncology Inc. logo

SEC Form 4: Aichele David sold $4,647 worth of shares (1,480 units at $3.14) as part of a pre-agreed trading plan, decreasing direct ownership by 0.68% to 215,987 units

ByQuantisnow·Wall Street's wire, on your screen.
AKTS· Aktis Oncology Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKTS (Aktis Oncology Inc.) and more on Quantisnow.